This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
IPV
and you are
between 6 and 12
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The investigators will assess the usability and immune response following fractional dose inactivated polio virus vaccine (fIPV) administration with two novel intradermal adapters (ID adapter by West Pharmaceutical services Inc. and Star Intradermal syringe by Star Syringe Ltd.) and compare the response with the one achieved with fIPV administered with traditional BCG needle syringe.

Provided treatments

  • Device: Westpharma ID adapter
  • Device: Star ID syringe
  • Device: BCG NS
Tris trial is registered with FDA with number: NCT02769923. The sponsor of the trial is Aga Khan University and it is looking for 450 volunteers for the current phase.
Official trial title:
Intradermal Administration of Fractional Dose of Inactivated Poliovirus Vaccine Using Intradermal Adapters vs. BCG Syringe: Community Based Randomized Control Trial in Pakistan